candidate substance optimization
Scope
Date
~
-
Bio & Pharma
Daewoong Pharmaceutical’s cumulative tech exports exceed $870 mn
South Korea’s Daewoong Pharmaceutical said on Friday that it had concluded three technology export agreements for new drugs and new drug candi...
May 12, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience to produce MSD’s new Ebola vaccine candidate
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, announced on Monday that it has signed a contract with MSD, a global pharma...
May 08, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
Samsung Heavy Industries develops next-generation FLNG
South Korean shipbuilder Samsung Heavy Industries has developed a new model for its floating liquefied natural gas (FLNG) production facility, aimed...
May 02, 2023 (Gmt+09:00)
-
Business & Politics
Elon Musk reaffirms Korea among top candidates for Asia Gigafactory
WASHINGTON, D.C. – Tesla Inc. Chief Executive Elon Musk said on Wednesday that South Korea is still among its top candidates to build another ...
Apr 27, 2023 (Gmt+09:00)
-
Aerospace & Defense
S.Korea-US to deepen aerospace ties through NASA's Artemis
South Korea and the US are set to deepen their partnership in the aerospace sector through the Artemis program, a human and robotic Moon exploration...
Apr 25, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
KT launches AI-based email security solution to combat APT attacks
KT Corp. said on Tuesday that it has unveiled an email security solution based on artificial intelligence (AI) advanced persistent threat (APT) anal...
Apr 11, 2023 (Gmt+09:00)
-
Cloud computing
S.Korea's Yanolja Cloud acquires US solution company InSoft
South Korea's Yanolja Cloud announced on Thursday that it has acquired InSoft, a US hospitality solution company, to establish a base for expanding ...
Apr 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea's CJ Bioscience buys drug candidates from 4D pharma of the UK
South Korea’s pharmaceutical and healthcare company CJ Bioscience Inc. has acquired drug candidates from the UK's 4D pharma plc. to improve co...
Mar 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Kwangdong introduces new drug candidate for pediatric myopia
South Korean pharmaceutical company Kwangdong Pharmaceutical announced on Monday that it has signed a contract with Hong Kong-based Zhaoke Ophthalmo...
Mar 27, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma receives 1st overseas patent for its hair loss treatment
JW Pharmaceutical, a drug company based in South Korea, has received its first patent for a hair loss treatment that is currently in development. Th...
Mar 27, 2023 (Gmt+09:00)
-
Cloud computing
Korea's LG CNS launches cloud cost optimization service
LG CNS, a South Korean company specializing in digital transformation, announced on Tuesday the launch of its new service called "FinOps" Clinic.Fin...
Mar 21, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion, Genuv sign agreement for antibody joint R&D
South Korean biopharmaceutical firm Celltrion Inc. announced on Tuesday a joint research and development agreement with Genuv, Inc., a domestic drug...
Mar 14, 2023 (Gmt+09:00)
-
Banking & Finance
KB Financial Group injects $385.6 million into S.Korea’s real estate PF
South Korea’s KB Financial Group on Monday said it will provide liquidity support for the domestic market for real estate project financing (P...
Mar 14, 2023 (Gmt+09:00)
-
Chemical Industry
SK Geo Centric optimizes plastic recycling tech with US company
SK Geo Centric Co., a South Korean energy and chemical company, is accelerating technical negotiations to build the world's first plastic recycling ...
Mar 10, 2023 (Gmt+09:00)
-
Bio & Pharma
OliX's hair loss treatment candidate approved for clinical trial in Australia
South Korea's OliX Pharmaceuticals has received approval from Australia's Human Research Ethics Committees (HREC) to plan a phase 1 clinical trial o...
Mar 10, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma introduces candidates for treating blood coagulation disease
South Korea's GC Biopharma Corp. announced on Tuesday that it had entered into an agreement to transfer assets with Catalyst Biosciences, a US-based...
Mar 02, 2023 (Gmt+09:00)
-
Bio & Pharma
SillaJen starts US trial of anti-cancer drug from Basilea
SillaJen Inc. said on Monday it has enrolled the first patient in a US phase 1 trial of an anti-cancer drug BAL0891 licensed from Swiss drugmaker Ba...
Feb 27, 2023 (Gmt+09:00)
-
Artificial intelligence
Hyundai Department Store uses AI to write advertising copy
South Korea's Hyundai Department Store Co. on Sunday said it will officially introduce on Thursday an artificial intelligence (AI) copywriting syste...
Feb 27, 2023 (Gmt+09:00)
-
Artificial intelligence
S.Korean IT firms rush for tie-ups to compete with ChatGPT
South Korean tech companies are rushing to form partnerships in different sectors to develop superior AI services to compete with ChatGPT, a chatbot...
Feb 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea's InCerebro to leverage AI to identify drug candidates
South Korean AI-based drug developer InCerebro aims to identify potential drug candidates using molecular modeling technology, according to its CEO ...
Feb 01, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Daewoong Pharmaceutical to export tech to British company
South Korea's Daewoong Pharmaceutical has licensed a new drug candidate for idiopathic pulmonary fibrosis (IPF) to CS Pharmaceuticals (CSP) of the U...
Feb 01, 2023 (Gmt+09:00)
-
Bio & Pharma
Bridge Biotherapeutics, Pinotbio develop lung cancer treatment
South Korea's biotech companies Bridge Biotherapeutics Inc. and Pinotbio on Thursday said they will jointly develop new antibody-drug conjugates (AD...
Jan 27, 2023 (Gmt+09:00)
-
Shareholder activism
Activist fund nominates director candidates for KT&G
A Singapore-based activist fund has stepped up pressure on the world’s fifth-largest tobacco maker KT&G Corp. to reform governance and boo...
Jan 19, 2023 (Gmt+09:00)
-
Bio & Pharma
MedPacto's anti-cancer substance designated as US FDA fast-track item
South Korean biotech company MedPacto Inc. ’s Vactosertib monotherapy for osteosarcoma patients has been designated as a fast-track developmen...
Jan 18, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
SK Telecom, Nokia demonstrate Korea's first open RAN base station
SK Telecom Co. said on Tuesday that it verified jointly with Nokia the stable 5G speed and coverage performance in a field test by installing a clou...
Jan 11, 2023 (Gmt+09:00)
-
Energy
POSCO to enter palm oil refining market in Indonesia
POSCO International Co., a trading arm of South Korea’s steel giant POSCO Co., will build a palm oil refining plant in Indonesia to foray into...
Jan 10, 2023 (Gmt+09:00)
-
Chemical Industry
Lotte Chemical conducts product risk assessment first time in Korea
Lotte Chemical Corp. said on Tuesday that it is conducting a risk assessment for its products for the first time in the domestic chemical industry...
Jan 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong, Onchorus to undertake research on mRNA anticancer drugs
Daewoong Pharmaceutical said on Thursday that it has signed a joint R&D and commercialization agreement with America's biopharmaceutical venture...
Jan 05, 2023 (Gmt+09:00)
-
Leadership & Management
KT taps current CEO Ku as sole candidate for next chief
South Korea’s telecom giant KT Corp. has named current chief executive Ku Hyeon-mo the sole candidate for its next CEO during a board meeting ...
Dec 28, 2022 (Gmt+09:00)
-
Bio & Pharma
CJ applies to FDA for trials of immuno-anticancer drug candidate
CJ Bioscience, an independent red bio (pharmaceutical and healthcare) subsidiary of CJ CheilJedang Corp., said on Monday it has submitted a phase 1 ...
Dec 26, 2022 (Gmt+09:00)
Latest News
- 1 NPS-backed new prime office struggles with poor demand
- 2 Affinity-backed SSG.COM offers first voluntary redundancy
- 3 Lotte to cut basic chemicals in portfolios for profitability
- 4 Young rich Koreans: Financially literate, self-directing
- 5 LG Elec logs record Q2 profit on home appliances, car parts